This series examines the impact of U.S. health funding cuts on cancer care and research, both domestically and globally.
In the U.S., reporting will investigate reductions in Medicaid and the Affordable Care Act, assessing their effects on cancer care in both urban and rural settings.
Reporting will also explore funding cuts at the National Cancer Institute, the Centers for Disease Control and Prevention, and the Food and Drug Administration, highlighting implications for clinical trials, research, and prevention programs, which in turn influence global health initiatives.
Internationally, reporting will evaluate how U.S. funding cuts—including those in the U.S. Agency for International Development (USAID) and the National Cancer Institute—affect global cancer care and research, with particular focus on the fight against cervical cancer and the World Health Organization’s leadership in cancer prevention in less affluent countries.
This project will include six in-depth articles and two videos focused on the U.S. findings, alongside two articles featuring global perspectives.
